Eagle Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-155,848
Closed -$3.32M 604
2024
Q2
$3.32M Sell
155,848
-20,394
-12% -$429K 0.02% 429
2024
Q1
$3.81M Buy
176,242
+20,136
+13% +$491K 0.02% 422
2023
Q4
$4.29M Sell
156,106
-767
-0.5% -$18.5K 0.02% 389
2023
Q3
$3.5M Sell
156,873
-14,623
-9% -$376K 0.02% 400
2023
Q2
$4.37M Sell
171,496
-5,596
-3% -$136K 0.02% 372
2023
Q1
$3.95M Buy
177,092
+4,373
+3% +$106K 0.02% 371
2022
Q4
$3.91M Sell
172,719
-61,695
-26% -$1.43M 0.02% 373
2022
Q3
$3.89M Sell
234,414
-6,853
-3% -$154K 0.03% 376
2022
Q2
$4.8M Buy
241,267
+160
+0.1% +$3.23K 0.03% 355
2022
Q1
$6.65M Sell
241,107
-8,203
-3% -$235K 0.03% 343
2021
Q4
$10.3M Sell
249,310
-35,974
-13% -$1.59M 0.05% 304
2021
Q3
$13.3M Sell
285,284
-371
-0.1% -$16.2K 0.06% 267
2021
Q2
$11.4M Buy
+285,655
New +$12.2M 0.05% 296

Other funds holding VCYT

Eagle Asset Management's VCYT Position: Q3 2024 in Review

Eagle Asset Management sold out of Veracyte (VCYT) in Q3 2024, closing a stake of 155,848 shares — an estimated $3.32M sold.

Eagle Asset Management first reported a position in VCYT in Q2 2021 and held it in 13 quarters. The position peaked at $13.3M in Q3 2021. 293 funds tracked by Wall St. Rank hold VCYT as of Q3 2024.

  • Eagle Asset Management reported no remaining Veracyte position as of Q3 2024 after selling out during the quarter.
  • Eagle Asset Management sold 155,848 Veracyte shares in Q3 2024, an estimated $3.32M.
  • Eagle Asset Management first reported a position in Veracyte in Q2 2021 and held it in 13 quarters.
  • Eagle Asset Management's Veracyte position peaked at $13.3M in Q3 2021.
  • 293 funds tracked by Wall St. Rank held Veracyte as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.